BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16376846)

  • 1. [Endoscopic treatment of Barrett's oesophagus].
    Boyer J
    Ann Chir; 2006 Jan; 131(1):7-11. PubMed ID: 16376846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Barrett's oesophagus: endoscopic diagnosis and follow-up].
    Ponsot P
    Ann Chir; 2006 Jan; 131(1):3-6. PubMed ID: 16376849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of Barrett's oesophagus. A general survey.
    Petrakis IE; Sciacca V; Iascone C
    Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results.
    Sharma P; Wani S; Weston AP; Bansal A; Hall M; Mathur S; Prasad A; Sampliner RE
    Gut; 2006 Sep; 55(9):1233-9. PubMed ID: 16905695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
    Foroulis CN; Thorpe JA
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus.
    Sujendran V; Sica G; Warren B; Maynard N
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):763-6. PubMed ID: 16188449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.
    Morris CD; Byrne JP; Armstrong GR; Attwood SE
    Br J Surg; 2001 Oct; 88(10):1357-62. PubMed ID: 11578292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.
    Attwood SE; Lewis CJ; Caplin S; Hemming K; Armstrong G
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):258-63. PubMed ID: 15017666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma.
    Weston AP; Sharma P
    Am J Gastroenterol; 2002 Dec; 97(12):2998-3006. PubMed ID: 12492182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD; Buckles D; Al-Kasspooles M
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular evaluation of ablative therapy of Barrett's oesophagus.
    Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
    J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma.
    Van Laethem JL; Jagodzinski R; Peny MO; Cremer M; Devière J
    Endoscopy; 2001 Mar; 33(3):257-61. PubMed ID: 11293760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation.
    Kelty CJ; Ackroyd R; Brown NJ; Stephenson TJ; Stoddard CJ; Reed MW
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1289-96. PubMed ID: 15606390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic ablation therapy for Barrett's esophagus with high-grade dysplasia: a review.
    van den Boogert J; van Hillegersberg R; Siersema PD; de Bruin RW; Tilanus HW
    Am J Gastroenterol; 1999 May; 94(5):1153-60. PubMed ID: 10235186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barrett's oesophagus: the new endoscopic modalities have a future.
    Deviere J
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i33-7. PubMed ID: 15711006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy.
    Schembre DB; Huang JL; Lin OS; Cantone N; Low DE
    Gastrointest Endosc; 2008 Apr; 67(4):595-601. PubMed ID: 18279860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.